InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the complete record of transactions filed by Foresite Capital Management IV, LLC. Director active across 2 companies, notably Kinnate Biopharma Inc.. In total, 4 disclosures have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €3.9m. History available since 8 May 2023. The latest transaction was filed on 4 February 2026 (C). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Foresite Capital Management IV, LLC is a declarant linked to Kinnate Biopharma Inc. and Eikon Therapeutics, Inc. It has 4 filings in total, and over the sampled recent filings, buys total 3949274 EUR and sells total 0 EUR, with a date range from 2023-02-22 to 2026-02-06.